文献速递腹部MR

基于Gd-EOB-DTPA增强MRI的影像特征预测肝细胞癌肿瘤簇包裹血管(VETC)

Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma.
PubMed 文献 · Br J Radiol · 2021-01-20

该回顾性研究纳入109例经病理确诊的肝细胞癌患者,评估Gd-EOB-DTPA增强MRI定性与定量影像特征预测VETC状态的价值。多因素分析显示AST>40 U/l、非环状弥漫不均匀动脉期高强化、动脉期肿瘤/肝脏信号强度比≥1.135、肝胆期肿瘤/肝脏信号强度比≤0.585为VETC阳性的独立预测因素,联合四项指标诊断准确率82.6%、敏感度83.9%、特异度80.9%,列线图AUC为0.885。

要点

  • 动脉期非环状弥漫不均匀高强化是VETC阳性肝细胞癌的定性影像征象。
  • 动脉期肿瘤/肝脏信号强度比≥1.135提示VETC阳性。
  • 肝胆期肿瘤/肝脏信号强度比≤0.585提示VETC阳性。

关键影像表现/征象

  • 动脉期非环状弥漫不均匀高强化是预测VETC阳性肝细胞癌的独立影像征象(p=0.035)。
  • 动脉期肿瘤/肝脏信号强度比≥1.135是预测VETC阳性肝细胞癌的独立定量指标(p=0.001)。
  • 肝胆期肿瘤/肝脏信号强度比≤0.585是预测VETC阳性肝细胞癌的独立定量指标(p=0.002)。

诊断标准与关键数值

  • 联合血清AST>40 U/l、非环状弥漫不均匀动脉期高强化、动脉期肿瘤/肝脏信号强度比≥1.135、肝胆期肿瘤/肝脏信号强度比≤0.585四项指标鉴别VETC状态,诊断准确率82.6%、敏感度83.9%、特异度80.9%。
  • 基于多因素分析系数构建的列线图AUC为0.885(95%CI 0.824-0.946)。

临床应用与阅片要点

  • 术前可依据动脉期强化模式及动脉期、肝胆期肿瘤/肝脏信号强度比评估肝细胞癌VETC状态,辅助预测患者预后及制定治疗方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the non-invasive prediction of hepatocellular carcinoma (HCC) with vessels encapsulating tumor clusters (VETC) based on qualitative and quantitative imaging features of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced MRI.

METHODS: 109 patients with pathologically confirmed HCC who underwent Gd-EOB-DTPA enhanced MRI and immunochemical staining for CD34 were retrospectively evaluated in our institution (the first affiliated hospital of Soochow university). Pre-operative imaging features of Gd-EOB-DTPA-enhanced MRI were qualitatively and quantitatively reviewed by radiologists. Significant variables for differentiating the VETC-positive and VETC-negative HCCs were identified in univariate and multivariate analyses. Receiver operating characteristic (ROC) analysis was performed to determine the optimal cut-off values for quantitative variables. The nomogram based on the coefficient of multivariate analysis was constructed to evaluate the probability of VETC-positive HCCs.

RESULTS: The multivariate analysis showed that the serum AST level >40 U l-1 (p = 0.007), non-rim diffuse and heterogeneous arterial phase hyperenhancement (p = 0.035), tumor-to-liver SI ratio of 1.135 or more on AP images (p = 0.001), and tumor-to-liver SI ratio of 0.585 or less on HBP images (p = 0.002) were significant predictors for predicting VETC-positive HCCs. Combing all four significant variables provided a diagnostic accuracy of 82.6%, sensitivity of 83.9%, specificity of 80.9% for identifying VETC status. The area under the receiver operating characteristics curve value of the logistical regression coefficient-based nomogram was 0.885 (95% confidence intervals, 0.824-0.946).

CONCLUSION: Qualitative and quantitative imaging features of Gd-EOB-DTPA-enhanced MRI integrating laboratory examination can provide good diagnostic performance.

ADVANCES IN KNOWLEDGE: VETC is a novel identified microvascular pattern; associations between imaging features and VETC status have not been investigated. Pre-operative diagnosis of VETC status in HCC is essential to help predict the outcome of patients and make a decision for the therapeutic schedule.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Fan Y, Yu Y, Hu M, et al. Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma. Br J Radiol. 2021. PMID: 33417489. doi:10.1259/bjr.20200950

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。